Terms: = Lung cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
84 results:
1. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Ha JL; Kaser E; Guan T; Mayberry TG; Smith LA; D'mello K; Bai Q; Wakefield MR; Dong L; Fang Y
Med Oncol; 2024 Jan; 41(3):65. PubMed ID: 38281234
[TBL] [Abstract] [Full Text] [Related]
2. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
Liang J; Bi G; Huang Y; Zhao G; Sui Q; Zhang H; Bian Y; Yin J; Wang Q; Chen Z; Zhan C
Drug Resist Updat; 2024 Mar; 73():101057. PubMed ID: 38266355
[TBL] [Abstract] [Full Text] [Related]
3. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of cdkn2c and SCEL.
Chen H; Su Y; Yang L; Xi L; Li X; Lan B; Liu M; Xuan C
J Cell Physiol; 2023 Nov; 238(11):2710-2723. PubMed ID: 37733753
[TBL] [Abstract] [Full Text] [Related]
4. Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Desai A; Rakshit S; Bansal R; Ashara Y; Potter A; Manochakian R; Lou Y; Zhao Y; Ernani V; Savvides P; Schwecke A; Moffett N; Hocum C; Leventakos K; Adjei A; Marks R; Molina J; Mansfield AS; Chen ZM; Dimou A
Cancer Treat Res Commun; 2023; 36():100743. PubMed ID: 37531736
[TBL] [Abstract] [Full Text] [Related]
5. Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation.
Lin YS; Chiang SF; Chen CY; Hong WZ; Chen TW; Chen WT; Ke TW; Yang PC; Liang JA; Shiau AC; Chao KSC; Huang KC
Cancer Immunol Immunother; 2023 Jul; 72(7):2283-2297. PubMed ID: 36881132
[TBL] [Abstract] [Full Text] [Related]
6. Feline pulmonary carcinoma: Gross, histological, metastatic, and immunohistochemical aspects.
Santos IR; Raiter J; Lamego ÉC; Bandinelli MB; Dal Pont TP; Siqueira KF; Almeida BA; Panzeira W; Sonne L; Driemeier D; Pavarini SP
Vet Pathol; 2023 Jan; 60(1):8-20. PubMed ID: 36112908
[TBL] [Abstract] [Full Text] [Related]
7. Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients.
Wan L; Wu C; Wu Q; Luo S; Liu J; Xie X
Cancer Med; 2023 Jan; 12(2):1841-1849. PubMed ID: 35770869
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract] [Full Text] [Related]
9. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
10. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
[TBL] [Abstract] [Full Text] [Related]
11. Patient-Derived In Vitro and In Vivo Models of cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract] [Full Text] [Related]
12. Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures.
Nakagawa K; Yoshida Y; Yotsukura M; Watanabe SI
Jpn J Clin Oncol; 2021 Nov; 51(11):1649-1655. PubMed ID: 34373902
[TBL] [Abstract] [Full Text] [Related]
13.
Kotake Y; Matsunaga N; Wakasaki T; Okada R
Cancer Genomics Proteomics; 2021; 18(4):543-548. PubMed ID: 34183387
[TBL] [Abstract] [Full Text] [Related]
14. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.
Tang J; Meng Q; Shi R; Xu Y
Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431
[TBL] [Abstract] [Full Text] [Related]
15. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other lung cancer Histologies.
Shen E; Xiu J; Bentley R; López GY; Walsh KM
Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
[TBL] [Abstract] [Full Text] [Related]
16. Voriconazole and the Risk of Keratinocyte Carcinomas Among lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
Zhang Y; Pavlov A; Malik S; Chen H; Kim N; Li Z; Zhang X; DePamphilis ML; Roeder RG; Ge H
PLoS One; 2020; 15(3):e0230670. PubMed ID: 32231397
[TBL] [Abstract] [Full Text] [Related]
18. A Regulatory Noncoding RNA, nc886, Suppresses Esophageal cancer by Inhibiting the AKT Pathway and Cell Cycle Progression.
Im WR; Lee HS; Lee YS; Lee JS; Jang HJ; Kim SY; Park JL; Lee Y; Kim MS; Lee JM; Kim IH; Jeon SH; Lee YS
Cells; 2020 Mar; 9(4):. PubMed ID: 32225025
[TBL] [Abstract] [Full Text] [Related]
19. Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.
Colinet B; Van Meerbeeck JP; Cuppens T; Vansteenkiste JF
Acta Clin Belg; 2021 Jun; 76(3):224-231. PubMed ID: 31935159
[No Abstract] [Full Text] [Related]
20. Validation of the Eighth Edition TNM lung cancer Staging System.
Hwang JK; Page BJ; Flynn D; Passmore L; McCaul E; Brady J; Yang IA; Marshall H; Windsor M; Bowman RV; Naidoo R; Guan T; Philpot S; Blake ME; Fong KM
J Thorac Oncol; 2020 Apr; 15(4):649-654. PubMed ID: 31863848
[TBL] [Abstract] [Full Text] [Related]
[Next]
